Published

Australia to prescribe MDMA and psilocybin for PTSD and depression in world first.

No abstract availability was recorded for this entry.

Open source BibTeX RIS

Bibliographic context

Journal: Nature
Date: 2023-07-01
Source: PubMed
DOI: 10.1038/d41586-023-02093-8
PubMed: 37386185

Authors

Haridy R

Watch author

Derived topics and classifications

psilocybin Depression PTSD Other

Citation graph

0 referenced DOIs found in stored source metadata. 2 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Regulatory ambiguity and governance challenges for psilocybin mushrooms in Brazil2026-04-01 Psilocybin-induced alterations in EEG power, connectivity and network dynamics in healthy subjects: Correlations with subjective experience and implications for therapeutic applications2026-03-01

Related papers

A Phase III, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With Treatment-resistant DepressionClinicalTrials.gov · 2026-08-10